Velan Capital Investment Management
$163M 13F equity value
55 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Velan Capital Investment Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 88,781 | $30M | 18.2% |
| MPLT | MAPLIGHT THERAPEUTICS INC | 492,893 | $18M | 10.8% |
| STRO | SUTRO BIOPHARMA INC | 512,160 | $17M | 10.4% |
| IMMX | IMMIX BIOPHARMA INC | 1,085,000 | $11M | 6.9% |
| TARA | PROTARA THERAPEUTICS INC | 2,844,652 | $11M | 6.7% |
| ABVX | ABIVAX SA | 65,630 | $9M | 5.4% |
| TENX | TENAX THERAPEUTICS INC | 549,985 | $8M | 4.9% |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 700,000 | $7M | 4.2% |
| EDSA | EDESA BIOTECH INC | 827,500 | $7M | 4.1% |
| EVMN | EVOMMUNE INC | 451,255 | $6M | 3.7% |
Track Velan Capital Investment Management's 13F portfolio: $163M in reported holdings, 55 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}